PORTAGE, Michigan - Medical (TASE:PMCN) technology company Stryker (NYSE:SYK), a prominent player in the Healthcare Equipment ...

The prospect of American forces operating in large-scale combat operations (LSCO) is becoming increasingly probable with the ...

The global Bunion Surgery Market, valued at US$437.8 million in 2023, is forecasted to grow at a robust CAGR of 5.7%, reaching US$458.4 million ...

Shares of robotic surgery pioneer Intuitive Surgical (NASDAQ: ISRG) have been soaring lately. A preliminary look at sales ...

According to a new market research report titled, 'Surgical Drills Market Size, Share, Forecast, & Trends Analysis by Product (Instruments [Pneumatic ...

The popular virtual Demystifying EMC event hosted by Rohde & Schwarz returns in 2025 to provide the latest educational ...

Stryker (SYK) agreed to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a family-owned investment firm ...

Regarding its outlook, Stryker logged expects organic sales growth of 8% to 9% for 2025, and adjusted earnings of $13.45 to $13.70 a share, as it sees sustained levels of procedural volumes and strong ...

Stryker Corporation's innovation and market leadership justify a premium. See why SYK stock is a solid hold with long-term ...

The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its ...

Stryker beat Wall Street estimates for fourth-quarter profit and forecast 2025 earnings largely above expectations on Tuesday, fueled by strong demand for its medical and surgical devices.

“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an independent company," said Kevin A. Lobo, Chair and Chief Executive Officer, ...